Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 7237

1.

Amyloid Beta1-42 and the Phoshorylated Tau Threonine 231 in Brains of Aged Cynomolgus Monkeys (Macaca fascicularis).

Darusman HS, Gjedde A, Sajuthi D, Schapiro SJ, Kalliokoski O, Kristianingrum YP, Handaryani E, Hau J.

Front Aging Neurosci. 2014 Nov 10;6:313. eCollection 2014.

PMID:
25426069
[PubMed - as supplied by publisher]
2.

Bioenergetic Dysfunction and Inflammation in Alzheimer's Disease: A Possible Connection.

Wilkins HM, Carl SM, Greenlief AC, Festoff BW, Swerdlow RH.

Front Aging Neurosci. 2014 Nov 10;6:311. eCollection 2014. Review.

PMID:
25426068
[PubMed - as supplied by publisher]
3.

Biomarkers in the Diagnosis and Prognosis of Alzheimer's Disease.

Schaffer C, Sarad N, DeCrumpe A, Goswami D, Herrmann S, Morales J, Patel P, Osborne J.

J Lab Autom. 2014 Nov 25. pii: 2211068214559979. [Epub ahead of print] Review.

PMID:
25424384
[PubMed - as supplied by publisher]
4.

Multi-Modal Neuroimaging Feature Learning for Multi-Class Diagnosis of Alzheimer's Disease.

Liu S, Liu S, Cai W, Che H, Pujol S, Kikinis R, Feng D, Fulham MJ.

IEEE Trans Biomed Eng. 2014 Nov 20. [Epub ahead of print]

PMID:
25423647
[PubMed - as supplied by publisher]
5.

Genetic Variants of GSK3B are Associated with Biomarkers for Alzheimer's Disease and Cognitive Function.

Kettunen P, Larsson S, Holmgren S, Olsson S, Minthon L, Zetterberg H, Blennow K, Nilsson S, Sjölander A.

J Alzheimers Dis. 2014 Nov 24. [Epub ahead of print]

PMID:
25420549
[PubMed - as supplied by publisher]
6.

Prevalence of mixed pathologies in the aging brain.

Rahimi J, Kovacs GG.

Alzheimers Res Ther. 2014 Nov 21;6(9):82. eCollection 2014.

PMID:
25419243
[PubMed - as supplied by publisher]
Free Article
7.

SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease.

Brinkmalm A, Brinkmalm G, Honer WG, Frölich L, Hausner L, Minthon L, Hansson O, Wallin A, Zetterberg H, Blennow K, Ohrfelt A.

Mol Neurodegener. 2014 Nov 23;9(1):53. [Epub ahead of print]

PMID:
25418885
[PubMed - as supplied by publisher]
Free Article
8.

Label-free detection of Alzheimer's disease through the ADP3 peptoid recognizing the serum amyloid-beta42 peptide.

Zhao Z, Zhu L, Bu X, Ma H, Yang S, Yang Y, Hu Z.

Chem Commun (Camb). 2014 Nov 24. [Epub ahead of print]

PMID:
25418132
[PubMed - as supplied by publisher]
9.

Superconductivity in human body; myth or necessity.

Alexiou A, Rekkas J.

Adv Exp Med Biol. 2015;822:53-8. doi: 10.1007/978-3-319-08927-0_8.

PMID:
25416976
[PubMed - in process]
10.

Micellar extraction possesses a new advantage for the analysis of Alzheimer's disease brain proteome.

Musunuri S, Kultima K, Richard BC, Ingelsson M, Lannfelt L, Bergquist J, Shevchenko G.

Anal Bioanal Chem. 2014 Nov 22. [Epub ahead of print]

PMID:
25416231
[PubMed - as supplied by publisher]
11.

On the comparison of a novel serious game and electroencephalography biomarkers for early dementia screening.

Tarnanas I, Laskaris N, Tsolaki M, Muri R, Nef T, Mosimann UP.

Adv Exp Med Biol. 2015;821:63-77. doi: 10.1007/978-3-319-08939-3_11.

PMID:
25416111
[PubMed - in process]
12.

Multimodality Imaging of Alzheimer Disease and Other Neurodegenerative Dementias.

Nasrallah IM, Wolk DA.

J Nucl Med. 2014 Nov 20. pii: jnumed.114.141416. [Epub ahead of print]

PMID:
25413136
[PubMed - as supplied by publisher]
13.

Aberrantly expressed mRNAs and long non-coding RNAs in patients with invasive ductal breast carcinoma: A pilot study.

Chen X, Yang J, Qian L, Cao T.

Mol Med Rep. 2014 Nov 20. doi: 10.3892/mmr.2014.2989. [Epub ahead of print]

PMID:
25411894
[PubMed - as supplied by publisher]
14.

Mass spectrometry for the detection of potential psychiatric biomarkers.

Ngounou Wetie AG, Sokolowska I, Wormwood K, Beglinger K, Michel TM, Thome J, Darie CC, Woods AG.

J Mol Psychiatry. 2013 Jun 5;1(1):8. eCollection 2013. Review.

PMID:
25408901
[PubMed - as supplied by publisher]
Free PMC Article
15.

JOINT IDENTIFICATION OF IMAGING AND PROTEOMICS BIOMARKERS OF ALZHEIMER'S DISEASE USING NETWORK-GUIDED SPARSE LEARNING.

Yan J, Huang H, Kim S, Moore J, Saykin A, Shen L.

Proc IEEE Int Symp Biomed Imaging. 2014 May;2014:665-668.

PMID:
25408822
[PubMed]
16.

Endostatin Level in Cerebrospinal Fluid of Patients with Alzheimer's Disease.

Salza R, Oudart JB, Ramont L, Maquart FX, Bakchine S, Thoannès H, Ricard-Blum S.

J Alzheimers Dis. 2014 Nov 18. [Epub ahead of print]

PMID:
25408220
[PubMed - as supplied by publisher]
17.

Sphingomyelin SM(d18:1/18:0) is Significantly Enhanced in Cerebrospinal Fluid Samples Dichotomized by Pathological Amyloid-β42, Tau, and Phospho-Tau-181 Levels.

Koal T, Klavins K, Seppi D, Kemmler G, Humpel C.

J Alzheimers Dis. 2014 Nov 14. [Epub ahead of print]

PMID:
25408209
[PubMed - as supplied by publisher]
18.

Peripheral α-Defensins 1 and 2 are Elevated in Alzheimer's Disease.

Watt AD, Perez KA, Ang CS, O'Donnell P, Rembach A, Pertile KK, Rumble RL, Trounson BO, Fowler CJ, Faux NG, Masters CL, Villemagne VL, Barnham KJ.

J Alzheimers Dis. 2014 Nov 14. [Epub ahead of print]

PMID:
25408207
[PubMed - as supplied by publisher]
19.

Models of beta-amyloid induced Tau-pathology: the long and "folded" road to understand the mechanism.

Stancu IC, Vasconcelos B, Terwel D, Dewachter I.

Mol Neurodegener. 2014 Nov 18;9(1):51. [Epub ahead of print]

PMID:
25407337
[PubMed - as supplied by publisher]
Free Article
20.

Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians.

Asih PR, Chatterjee P, Verdile G, Gupta VB, Trengove RD, Martins RN.

Neurodegener Dis Manag. 2014 Oct;4(5):363-78. doi: 10.2217/nmt.14.29.

PMID:
25405650
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk